We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $2.04B
1-Year Est. Return 94.26%
This Fund
S&P 500
This Quarter Est. Return
-5.98%
1 Year Est. Return
+94.26%
3 Year Est. Return
+310.51%
5 Year Est. Return
+306.13%
10 Year Est. Return
+3,783.92%
AUM
$1.92B
AUM Growth
-$382M
Cap. Flow
-$14.9M
Cap. Flow %
-0.78%
Top 10 Hldgs %
45.28%
Holding
275
New
41
Increased
31
Reduced
101
Closed
38

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$24.8M
2
ASTH icon
Astrana Health
ASTH
+$16.6M
3
KSPI icon
Kaspi.kz JSC
KSPI
+$15.8M
4
LLY icon
Eli Lilly
LLY
+$15.2M
5
GPC icon
Genuine Parts
GPC
+$13M

Top Sells

Rank Stock Value
1
UWMC icon
UWM Holdings
UWMC
+$30.9M
2
WDC icon
Western Digital
WDC
+$24.7M
3
HRMY icon
Harmony Biosciences
HRMY
+$13.6M
4
SUNC
SunocoCorp LLC
SUNC
+$11.6M
5
GXO icon
GXO Logistics
GXO
+$10.6M

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.73%
2 Healthcare 23.91%
3 Consumer Discretionary 7.8%
4 Financials 6.79%
5 Industrials 3.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FOSL icon
151
Fossil Group
FOSL
$316M
$754K 0.04%
175,000
-83,065
-32% -$335K
AMTX icon
152
Aemetis
AMTX
$134M
$751K 0.04%
235,557
– –
KYTX icon
153
Kyverna Therapeutics
KYTX
$518M
$734K 0.04%
85,000
-29,900
-26% -$249K
DUOT icon
154
Duos Technologies
DUOT
$294M
$730K 0.04%
106,481
– –
CTNM
155
Contineum Therapeutics
CTNM
$641M
$718K 0.04%
55,000
-36,442
-40% -$489K
UMAC icon
156
Unusual Machines
UMAC
$1.2B
$682K 0.04%
55,000
-29,751
-35% -$453K
SPCE icon
157
Virgin Galactic
SPCE
$446M
$681K 0.04%
280,160
– –
LODE icon
158
Comstock
LODE
$258M
$671K 0.04%
220,000
-56,243
-20% -$184K
SGMT icon
159
Sagimet Biosciences
SGMT
$656M
$660K 0.03%
126,349
– –
MODD icon
160
Modular Medical
MODD
$28.2M
$660K 0.03%
125,001
+66,264
+113% +$710K
ZURA icon
161
Zura Bio
ZURA
$548M
$655K 0.03%
110,000
-149,165
-58% -$901K
LPTH icon
162
Lightpath Technologies
LPTH
$705M
$652K 0.03%
65,000
-68,595
-51% -$787K
CAE icon
163
CAE Inc
CAE
$7.81B
$651K 0.03%
25,000
– –
VTVT icon
164
vTv Therapeutics
VTVT
$128M
$635K 0.03%
16,000
-2,268
-12% -$82.3K
CLYM
165
Climb Bio
CLYM
$837M
$617K 0.03%
90,000
-111,652
-55% -$644K
MRAM icon
166
Everspin Technologies
MRAM
$403M
$615K 0.03%
70,000
-39,943
-36% -$440K
GSIT icon
167
GSI Technology
GSIT
$219M
$611K 0.03%
118,835
– –
CABA icon
168
Cabaletta Bio
CABA
$529M
$605K 0.03%
225,000
-163,562
-42% -$454K
ELTX icon
169
Elicio Therapeutics
ELTX
$74.6M
$603K 0.03%
56,442
– –
ACHV icon
170
Achieve Life Sciences
ACHV
$834M
$588K 0.03%
200,000
-14,897
-7% -$66.2K
CCLD icon
171
CareCloud
CCLD
$106M
$583K 0.03%
159,761
– –
LTRX icon
172
Lantronix
LTRX
$251M
$576K 0.03%
110,000
-96,398
-47% -$589K
FCEL icon
173
FuelCell Energy
FCEL
$1.42B
$556K 0.03%
85,110
-34,890
-29% -$269K
BDTX icon
174
Black Diamond Therapeutics
BDTX
$128M
$528K 0.03%
247,958
– –
HYMC icon
175
Hycroft Mining Holding Corp
HYMC
$2.22B
$528K 0.03%
15,000
-35,000
-70% -$1.35M
5 6
7
8 9

Similar funds

SFI
Siemens Fonds Invest Munich, Germany $2.04B AUM 40.78% 1-Year Est. Return
UF
Univest Financial Souderton, Pennsylvania $2.04B AUM 33.06% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $2.04B AUM 35.27% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.04B AUM 31.03% 1-Year Est. Return
C
Certuity North Palm Beach, Florida $2.03B AUM 88.59% 1-Year Est. Return
EF
Evanson Financial Mclean, Virginia $2.04B AUM
JCM
Jacobi Capital Management Pittston, Pennsylvania $2.04B AUM 26.26% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return

683 Capital Management's Q1 2026 Portfolio in Review

As of Q1 2026, 683 Capital Management held 275 positions worth $1.92B, down 17% from $2.3B the previous quarter. Its ten largest holdings account for 45% of the portfolio.

683 Capital Management's Q1 2026 filing shows 41 new, 31 increased, 101 reduced and 38 closed positions. Its largest new stake was Astrana Health: 700,000 shares worth $17.2M. The largest sale was UWM Holdings, an estimated $30.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 50% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • 683 Capital Management's largest Q1 2026 buy was Astrana Health: 700,000 shares worth $17.2M.
  • 683 Capital Management added most to Becton Dickinson in Q1 2026, an estimated $24.8M increase.
  • 683 Capital Management's biggest Q1 2026 reduction was GXO Logistics, cutting an estimated $10.6M.
  • 683 Capital Management fully exited UWM Holdings in Q1 2026, selling an estimated $30.9M.
  • 683 Capital Management's ten largest holdings make up 45% of its $1.92B portfolio in Q1 2026.
  • 683 Capital Management opened 41 new positions and closed 38 in Q1 2026.
  • 683 Capital Management's portfolio value fell 17% quarter-over-quarter to $1.92B.

Based on 683 Capital Management's 13F filing for Q1 2026, filed 15 May 2026.